David R. Sibley / Israel Hanin / Michael Kuhar / Phil Skolnick (eds.)

Gebundenes Buch

Handbook of Contemporary Neuropharmacology, 3 Volume Set

Beschreibung

A comprehensive, accessible reference for neuropharmacology

Recognizing the central role of neuropharmacology in drug development, therapy, and the potential for developing novel classes of neuropharmacologic agents stemming from current research, prominent experts collaborated to develop this comprehensive, up-to-date reference that consolidates information about the latest approaches and advances in neuropharmacology in general, and in the research and treatment of specific conditions. Edited by leaders in neuropharmacology and featuring chapters by respected authorities in their specialty areas, Handbook of Contemporary Neuropharmacology is an invaluable resource for pharmacologists, neurologists, psychiatrists, pharmaceutical professionals, and students. It covers basic neuropharmacology and then delves into its applications in research and in treating specific disorders:
_ Mood Disorders
_ Anxiety and Stress Disorders
_ Schizophrenia and Psychosis
_ Substance Abuse and Addictive Disorders
_ Pain
_ Sleep and Arousal
_ Development and Developmental Disorders
_ Neurodegenerative and Seizure Disorders
_ Neuroimmunology
_ Eating and Metabolic Disorders

Autor

DAVID R. SIBLEY, PhD, is a Senior Investigator and Chief of the Molecular Neuropharmacology Section in the National Institute of Neurological Disorders and Stroke, National Institutes of Health. His laboratory is currently investigating the molecular, cellular, and biochemical properties of dopamine receptors and their role in neuronal signaling and pathophysiological states. ISRAEL HANIN, PhD, is Professor and Chair Emeritus in the Department of Pharmacology at Loyola University Chicago. He formerly worked at the National Institute of Mental Health, Laboratory of Preclinical Pharmacology, and at the University of Pittsburgh Department of Psychiatry. Dr. Hanin's research has focused on cholinergic mechanisms, animal models for Alzheimer's disease, and the potential role of glycosaminoglycans in the treatment of Alzheimer's disease. MICHAEL KUHAR, PhD, is currently a Candler Professor and Georgia Research Alliance Professor of Neuropharmacology at the Yerkes Primate Center at Emory University. He previously was a professor in the Neuroscience Department at Johns Hopkins, and a branch chief at the National Institute on Drug Abuse. Dr. Kuhar has published more than 800 articles, abstracts, book chapters, reviews, and patents. PHIL SKOLNICK, PhD, D.Sc. (hon.), is Executive Vice President and Chief Scientific Officer for DOV Pharmaceutical, Inc. He was formerly a Lilly Fellow in Neuroscience and also served as Chief of the Laboratory of Neuroscience, National Institutes of Health.

Produktdetails

• Verlag: Wiley & Sons
• Artikelnr. des Verlages: 14666053000
• 1. Auflage
• Seitenzahl: 2992
• Erscheinungstermin: 30. März 2007
• Englisch
• Abmessung: 275mm x 210mm x 172mm
• Gewicht: 5570g
• ISBN-13: 9780471660538
• ISBN-10: 0471660531
• Artikelnr.: 22012031

Rezensionen

"...an admirable job of bringing together many aspects of neuropharmacology in one place...well worth your while to examine it." ( Journal of Medicinal Chemistry , September 20, 2007)